![Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages | BMC Microbiology | Full Text Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages | BMC Microbiology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12866-020-01953-x/MediaObjects/12866_2020_1953_Fig6_HTML.png)
Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages | BMC Microbiology | Full Text
![Fitness factors of E. coli Nissle 1917. The probiotic E. coli Nissle... | Download Scientific Diagram Fitness factors of E. coli Nissle 1917. The probiotic E. coli Nissle... | Download Scientific Diagram](https://www.researchgate.net/publication/235778239/figure/fig2/AS:339796036734992@1458025096595/Fitness-factors-of-E-coli-Nissle-1917-The-probiotic-E-coli-Nissle-1917-possesses.png)
Fitness factors of E. coli Nissle 1917. The probiotic E. coli Nissle... | Download Scientific Diagram
![Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications - Food & Function (RSC Publishing) DOI:10.1039/D2FO00226D Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications - Food & Function (RSC Publishing) DOI:10.1039/D2FO00226D](https://pubs.rsc.org/image/article/2022/FO/d2fo00226d/d2fo00226d-f2_hi-res.gif)
Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications - Food & Function (RSC Publishing) DOI:10.1039/D2FO00226D
![Frontiers | The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ Frontiers | The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ](https://www.frontiersin.org/files/Articles/374616/fmicb-09-00929-HTML/image_m/fmicb-09-00929-t001.jpg)
Frontiers | The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
![Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917 | Semantic Scholar Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917 | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e3ecede608a5c372309781cc1d2e080e85191011/2-Figure1-1.png)
Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917 | Semantic Scholar
![Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications - Food & Function (RSC Publishing) DOI:10.1039/D2FO00226D Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications - Food & Function (RSC Publishing) DOI:10.1039/D2FO00226D](https://pubs.rsc.org/image/article/2022/FO/d2fo00226d/d2fo00226d-f1_hi-res.gif)
Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications - Food & Function (RSC Publishing) DOI:10.1039/D2FO00226D
![Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance | Scientific Reports Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep17324/MediaObjects/41598_2015_Article_BFsrep17324_Fig1_HTML.jpg)
Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance | Scientific Reports
![Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy | Journal of Biological Engineering | Full Text Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy | Journal of Biological Engineering | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13036-019-0189-9/MediaObjects/13036_2019_189_Fig1_HTML.png)
Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy | Journal of Biological Engineering | Full Text
Prof. Dr. Meltem Yalınay | Escherichia coli Nissle 1917 suşunu (yalnızca Nissle 1917- yanına faklı suş kodları girince bakteri farklılaşır) ve preparatı E... | Instagram
![Escherichia coli strain Nissle 1917 (Mutaflor®,) enteric coated hard capsule finished product (probiotic) | Pharma Zentrale GmbH | CPHI Online Escherichia coli strain Nissle 1917 (Mutaflor®,) enteric coated hard capsule finished product (probiotic) | Pharma Zentrale GmbH | CPHI Online](https://www.cphi-online.com/46/product/80/40/12/Mutaflor-01.png)
Escherichia coli strain Nissle 1917 (Mutaflor®,) enteric coated hard capsule finished product (probiotic) | Pharma Zentrale GmbH | CPHI Online
![Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut | Nature Communications Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-13336-6/MediaObjects/41467_2019_13336_Fig1_HTML.png)
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut | Nature Communications
![Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV. - Abstract - Europe PMC Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7271297/bin/40200_2020_511_Fig1_HTML.jpg)
Intestinal effect of the probiotic Escherichia coli strain Nissle 1917 and its OMV. - Abstract - Europe PMC
Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications - Food & Function (RSC Publishing)
![Quorum sensing in the probiotic bacterium Escherichia coli Nissle 1917 (Mutaflor) – evidence that furanosyl borate diester (AI-2) is influencing the cytokine expression in the DSS colitis mouse model | Gut Pathogens | Full Text Quorum sensing in the probiotic bacterium Escherichia coli Nissle 1917 (Mutaflor) – evidence that furanosyl borate diester (AI-2) is influencing the cytokine expression in the DSS colitis mouse model | Gut Pathogens | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1757-4749-4-8/MediaObjects/13099_2012_Article_64_Fig7_HTML.jpg)
Quorum sensing in the probiotic bacterium Escherichia coli Nissle 1917 (Mutaflor) – evidence that furanosyl borate diester (AI-2) is influencing the cytokine expression in the DSS colitis mouse model | Gut Pathogens | Full Text
![Probiotic Escherichia coli Nissle 1917 propelled micro-robot with pH sensitivity for hypoxia targeted intestinal tumor therapy - ScienceDirect Probiotic Escherichia coli Nissle 1917 propelled micro-robot with pH sensitivity for hypoxia targeted intestinal tumor therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0927776523001558-ga1.jpg)
Probiotic Escherichia coli Nissle 1917 propelled micro-robot with pH sensitivity for hypoxia targeted intestinal tumor therapy - ScienceDirect
![Frontiers | The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ Frontiers | The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ](https://www.frontiersin.org/files/Articles/374616/fmicb-09-00929-HTML/image_m/fmicb-09-00929-g001.jpg)
Frontiers | The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
![Symbiosis culture of probiotic Escherichia coli Nissle 1917 and Lactobacillus rhamnosus GG using lactate utilization protein YkgG - ScienceDirect Symbiosis culture of probiotic Escherichia coli Nissle 1917 and Lactobacillus rhamnosus GG using lactate utilization protein YkgG - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S135951132300017X-ga1.jpg)